nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2A—chronic obstructive pulmonary disease	0.356	1	CbGaD
Risperidone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0327	0.147	CbGbCtD
Risperidone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0327	0.147	CbGbCtD
Risperidone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0292	0.131	CbGbCtD
Risperidone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0275	0.124	CbGbCtD
Risperidone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0185	0.0835	CbGbCtD
Risperidone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0177	0.0797	CbGbCtD
Risperidone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0158	0.071	CbGbCtD
Risperidone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0154	0.0695	CbGbCtD
Risperidone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0146	0.0657	CbGbCtD
Risperidone—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00973	0.216	CbGeAlD
Risperidone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00925	0.0417	CbGbCtD
Risperidone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00874	0.0394	CbGbCtD
Risperidone—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00566	0.126	CbGeAlD
Risperidone—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00353	0.0784	CbGeAlD
Risperidone—H1F0—respiratory system—chronic obstructive pulmonary disease	0.00154	0.0343	CbGeAlD
Risperidone—Paliperidone—HTR2A—chronic obstructive pulmonary disease	0.00148	0.396	CrCbGaD
Risperidone—H1F0—connective tissue—chronic obstructive pulmonary disease	0.00136	0.0302	CbGeAlD
Risperidone—H1F0—bronchus—chronic obstructive pulmonary disease	0.00127	0.0282	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—chronic obstructive pulmonary disease	0.00124	0.0276	CbGeAlD
Risperidone—Iloperidone—CYP1A2—chronic obstructive pulmonary disease	0.00123	0.328	CrCbGaD
Risperidone—H1F0—trachea—chronic obstructive pulmonary disease	0.00114	0.0253	CbGeAlD
Risperidone—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.00105	0.0234	CbGeAlD
Risperidone—Iloperidone—HTR2A—chronic obstructive pulmonary disease	0.00104	0.277	CrCbGaD
Risperidone—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000953	0.0211	CbGeAlD
Risperidone—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000901	0.02	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000896	0.0199	CbGeAlD
Risperidone—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000839	0.0186	CbGeAlD
Risperidone—H1F0—lung—chronic obstructive pulmonary disease	0.00082	0.0182	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000767	0.017	CbGeAlD
Risperidone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000733	0.0163	CbGeAlD
Risperidone—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000721	0.016	CbGeAlD
Risperidone—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000711	0.0158	CbGeAlD
Risperidone—HTR7—trachea—chronic obstructive pulmonary disease	0.000704	0.0156	CbGeAlD
Risperidone—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000647	0.0144	CbGeAlD
Risperidone—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000626	0.0139	CbGeAlD
Risperidone—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000615	0.0136	CbGeAlD
Risperidone—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000594	0.0132	CbGeAlD
Risperidone—HTR2B—lung—chronic obstructive pulmonary disease	0.000591	0.0131	CbGeAlD
Risperidone—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000575	0.0128	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000573	0.0127	CbGeAlD
Risperidone—HRH1—trachea—chronic obstructive pulmonary disease	0.000526	0.0117	CbGeAlD
Risperidone—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000523	0.0116	CbGeAlD
Risperidone—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000516	0.0115	CbGeAlD
Risperidone—HTR7—lung—chronic obstructive pulmonary disease	0.000506	0.0112	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000478	0.0106	CbGeAlD
Risperidone—DRD2—lung—chronic obstructive pulmonary disease	0.000478	0.0106	CbGeAlD
Risperidone—ADRA2C—lung—chronic obstructive pulmonary disease	0.000465	0.0103	CbGeAlD
Risperidone—HTR2A—trachea—chronic obstructive pulmonary disease	0.000439	0.00974	CbGeAlD
Risperidone—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000389	0.00864	CbGeAlD
Risperidone—CYP3A5—lung—chronic obstructive pulmonary disease	0.000389	0.00864	CbGeAlD
Risperidone—HRH1—lung—chronic obstructive pulmonary disease	0.000378	0.00838	CbGeAlD
Risperidone—ADRA2A—lung—chronic obstructive pulmonary disease	0.000371	0.00823	CbGeAlD
Risperidone—HTR2A—lung—chronic obstructive pulmonary disease	0.000315	0.007	CbGeAlD
Risperidone—ABCB1—trachea—chronic obstructive pulmonary disease	0.000288	0.00638	CbGeAlD
Risperidone—ABCB1—lung—chronic obstructive pulmonary disease	0.000207	0.00459	CbGeAlD
Risperidone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000565	CcSEcCtD
Risperidone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000565	CcSEcCtD
Risperidone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000565	CcSEcCtD
Risperidone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.000562	CcSEcCtD
Risperidone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000562	CcSEcCtD
Risperidone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000561	CcSEcCtD
Risperidone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00056	CcSEcCtD
Risperidone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00056	CcSEcCtD
Risperidone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000558	CcSEcCtD
Risperidone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000557	CcSEcCtD
Risperidone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000555	CcSEcCtD
Risperidone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000552	CcSEcCtD
Risperidone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000552	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000551	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000551	CcSEcCtD
Risperidone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000547	CcSEcCtD
Risperidone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000547	CcSEcCtD
Risperidone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000545	CcSEcCtD
Risperidone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.000544	CcSEcCtD
Risperidone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000542	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00054	CcSEcCtD
Risperidone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000539	CcSEcCtD
Risperidone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000539	CcSEcCtD
Risperidone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000538	CcSEcCtD
Risperidone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000538	CcSEcCtD
Risperidone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000536	CcSEcCtD
Risperidone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000534	CcSEcCtD
Risperidone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000533	CcSEcCtD
Risperidone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000533	CcSEcCtD
Risperidone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000532	CcSEcCtD
Risperidone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00053	CcSEcCtD
Risperidone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000527	CcSEcCtD
Risperidone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.000526	CcSEcCtD
Risperidone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000524	CcSEcCtD
Risperidone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000522	CcSEcCtD
Risperidone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000522	CcSEcCtD
Risperidone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000522	CcSEcCtD
Risperidone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000522	CcSEcCtD
Risperidone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000522	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00052	CcSEcCtD
Risperidone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000138	0.000517	CcSEcCtD
Risperidone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.000517	CcSEcCtD
Risperidone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.000517	CcSEcCtD
Risperidone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000138	0.000517	CcSEcCtD
Risperidone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000517	CcSEcCtD
Risperidone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000516	CcSEcCtD
Risperidone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000516	CcSEcCtD
Risperidone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000513	CcSEcCtD
Risperidone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000512	CcSEcCtD
Risperidone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000511	CcSEcCtD
Risperidone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000509	CcSEcCtD
Risperidone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000508	CcSEcCtD
Risperidone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000135	0.000507	CcSEcCtD
Risperidone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000506	CcSEcCtD
Risperidone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000505	CcSEcCtD
Risperidone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000504	CcSEcCtD
Risperidone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000504	CcSEcCtD
Risperidone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000503	CcSEcCtD
Risperidone—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000503	CcSEcCtD
Risperidone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.000501	CcSEcCtD
Risperidone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.000501	CcSEcCtD
Risperidone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000499	CcSEcCtD
Risperidone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000499	CcSEcCtD
Risperidone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000499	CcSEcCtD
Risperidone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.000498	CcSEcCtD
Risperidone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000497	CcSEcCtD
Risperidone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.000496	CcSEcCtD
Risperidone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.000495	CcSEcCtD
Risperidone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000132	0.000495	CcSEcCtD
Risperidone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000494	CcSEcCtD
Risperidone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000493	CcSEcCtD
Risperidone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000493	CcSEcCtD
Risperidone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000489	CcSEcCtD
Risperidone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000489	CcSEcCtD
Risperidone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000485	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000484	CcSEcCtD
Risperidone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000484	CcSEcCtD
Risperidone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000481	CcSEcCtD
Risperidone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000481	CcSEcCtD
Risperidone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000478	CcSEcCtD
Risperidone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000478	CcSEcCtD
Risperidone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000478	CcSEcCtD
Risperidone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000478	CcSEcCtD
Risperidone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000477	CcSEcCtD
Risperidone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000477	CcSEcCtD
Risperidone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000473	CcSEcCtD
Risperidone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.000473	CcSEcCtD
Risperidone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.000472	CcSEcCtD
Risperidone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.000472	CcSEcCtD
Risperidone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000471	CcSEcCtD
Risperidone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000471	CcSEcCtD
Risperidone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00047	CcSEcCtD
Risperidone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00047	CcSEcCtD
Risperidone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000468	CcSEcCtD
Risperidone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000468	CcSEcCtD
Risperidone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000468	CcSEcCtD
Risperidone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000467	CcSEcCtD
Risperidone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000464	CcSEcCtD
Risperidone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000461	CcSEcCtD
Risperidone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000461	CcSEcCtD
Risperidone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000459	CcSEcCtD
Risperidone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000454	CcSEcCtD
Risperidone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000452	CcSEcCtD
Risperidone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000452	CcSEcCtD
Risperidone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000446	CcSEcCtD
Risperidone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000446	CcSEcCtD
Risperidone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000445	CcSEcCtD
Risperidone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000444	CcSEcCtD
Risperidone—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000444	CcSEcCtD
Risperidone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000441	CcSEcCtD
Risperidone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000437	CcSEcCtD
Risperidone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000434	CcSEcCtD
Risperidone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000434	CcSEcCtD
Risperidone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000428	CcSEcCtD
Risperidone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000428	CcSEcCtD
Risperidone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000427	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000427	CcSEcCtD
Risperidone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000425	CcSEcCtD
Risperidone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000422	CcSEcCtD
Risperidone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000421	CcSEcCtD
Risperidone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000419	CcSEcCtD
Risperidone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000414	CcSEcCtD
Risperidone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000414	CcSEcCtD
Risperidone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000412	CcSEcCtD
Risperidone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000411	CcSEcCtD
Risperidone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00041	CcSEcCtD
Risperidone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000408	CcSEcCtD
Risperidone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000405	CcSEcCtD
Risperidone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000404	CcSEcCtD
Risperidone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000401	CcSEcCtD
Risperidone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.0004	CcSEcCtD
Risperidone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000106	0.0004	CcSEcCtD
Risperidone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000392	CcSEcCtD
Risperidone—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000392	CcSEcCtD
Risperidone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000391	CcSEcCtD
Risperidone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000386	CcSEcCtD
Risperidone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000385	CcSEcCtD
Risperidone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000385	CcSEcCtD
Risperidone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000381	CcSEcCtD
Risperidone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000381	CcSEcCtD
Risperidone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000381	CcSEcCtD
Risperidone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000381	CcSEcCtD
Risperidone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000381	CcSEcCtD
Risperidone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000379	CcSEcCtD
Risperidone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000379	CcSEcCtD
Risperidone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000379	CcSEcCtD
Risperidone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000378	CcSEcCtD
Risperidone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000378	CcSEcCtD
Risperidone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000378	CcSEcCtD
Risperidone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000377	CcSEcCtD
Risperidone—Rash—Montelukast—chronic obstructive pulmonary disease	9.94e-05	0.000374	CcSEcCtD
Risperidone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.93e-05	0.000373	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.9e-05	0.000373	CcSEcCtD
Risperidone—Depression—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000372	CcSEcCtD
Risperidone—Headache—Montelukast—chronic obstructive pulmonary disease	9.87e-05	0.000371	CcSEcCtD
Risperidone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000368	CcSEcCtD
Risperidone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.000367	CcSEcCtD
Risperidone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000366	CcSEcCtD
Risperidone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000366	CcSEcCtD
Risperidone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.66e-05	0.000363	CcSEcCtD
Risperidone—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.63e-05	0.000362	CcSEcCtD
Risperidone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.59e-05	0.000361	CcSEcCtD
Risperidone—Rash—Salbutamol—chronic obstructive pulmonary disease	9.58e-05	0.00036	CcSEcCtD
Risperidone—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.57e-05	0.00036	CcSEcCtD
Risperidone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.57e-05	0.00036	CcSEcCtD
Risperidone—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.56e-05	0.000359	CcSEcCtD
Risperidone—Nausea—Formoterol—chronic obstructive pulmonary disease	9.56e-05	0.000359	CcSEcCtD
Risperidone—Headache—Salbutamol—chronic obstructive pulmonary disease	9.52e-05	0.000358	CcSEcCtD
Risperidone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.000353	CcSEcCtD
Risperidone—Nausea—Montelukast—chronic obstructive pulmonary disease	9.36e-05	0.000352	CcSEcCtD
Risperidone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000348	CcSEcCtD
Risperidone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.22e-05	0.000347	CcSEcCtD
Risperidone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000341	CcSEcCtD
Risperidone—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.02e-05	0.000339	CcSEcCtD
Risperidone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.98e-05	0.000338	CcSEcCtD
Risperidone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000337	CcSEcCtD
Risperidone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000335	CcSEcCtD
Risperidone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000329	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000328	CcSEcCtD
Risperidone—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000328	CcSEcCtD
Risperidone—Shock—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.000322	CcSEcCtD
Risperidone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.5e-05	0.00032	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.000317	CcSEcCtD
Risperidone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000313	CcSEcCtD
Risperidone—Flushing—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000311	CcSEcCtD
Risperidone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000304	CcSEcCtD
Risperidone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000303	CcSEcCtD
Risperidone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000299	CcSEcCtD
Risperidone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.88e-05	0.000296	CcSEcCtD
Risperidone—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000296	CcSEcCtD
Risperidone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.82e-05	0.000294	CcSEcCtD
Risperidone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000294	CcSEcCtD
Risperidone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000292	CcSEcCtD
Risperidone—Erythema—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000292	CcSEcCtD
Risperidone—Pain—Prednisolone—chronic obstructive pulmonary disease	7.45e-05	0.00028	CcSEcCtD
Risperidone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000275	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000271	CcSEcCtD
Risperidone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.18e-05	0.00027	CcSEcCtD
Risperidone—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.00027	CcSEcCtD
Risperidone—Agitation—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000268	CcSEcCtD
Risperidone—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000267	CcSEcCtD
Risperidone—Malaise—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000263	CcSEcCtD
Risperidone—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000262	CcSEcCtD
Risperidone—Syncope—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000262	CcSEcCtD
Risperidone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.00026	CcSEcCtD
Risperidone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000256	CcSEcCtD
Risperidone—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000253	CcSEcCtD
Risperidone—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000252	CcSEcCtD
Risperidone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000248	CcSEcCtD
Risperidone—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000248	CcSEcCtD
Risperidone—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000248	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000247	CcSEcCtD
Risperidone—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000245	CcSEcCtD
Risperidone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.42e-05	0.000241	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000238	CcSEcCtD
Risperidone—Oedema—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000238	CcSEcCtD
Risperidone—Infection—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000237	CcSEcCtD
Risperidone—Shock—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000234	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000233	CcSEcCtD
Risperidone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000232	CcSEcCtD
Risperidone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000231	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.00023	CcSEcCtD
Risperidone—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000227	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000217	CcSEcCtD
Risperidone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000217	CcSEcCtD
Risperidone—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000215	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000214	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.00021	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000207	CcSEcCtD
Risperidone—Rash—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000207	CcSEcCtD
Risperidone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000206	CcSEcCtD
Risperidone—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000205	CcSEcCtD
Risperidone—Headache—Prednisolone—chronic obstructive pulmonary disease	5.46e-05	0.000205	CcSEcCtD
Risperidone—Constipation—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000204	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000196	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000195	CcSEcCtD
Risperidone—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.18e-05	0.000195	CcSEcCtD
Risperidone—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000189	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000188	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000188	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000175	CcSEcCtD
Risperidone—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.000171	CcSEcCtD
Risperidone—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000168	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000163	CcSEcCtD
Risperidone—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000157	CcSEcCtD
Risperidone—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000151	CcSEcCtD
Risperidone—Rash—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.00015	CcSEcCtD
Risperidone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.00015	CcSEcCtD
Risperidone—Headache—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000149	CcSEcCtD
Risperidone—Nausea—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000141	CcSEcCtD
Risperidone—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	9.84e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.06e-05	9.83e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.05e-05	9.79e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.05e-05	9.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	9.73e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.04e-05	9.72e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.04e-05	9.67e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.04e-05	9.66e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.03e-05	9.62e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	9.57e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	9.57e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.02e-05	9.51e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.01e-05	9.42e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	9.41e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.01e-05	9.39e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1e-05	9.33e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.96e-06	9.29e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.91e-06	9.24e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.89e-06	9.22e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.84e-06	9.17e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.8e-06	9.13e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.78e-06	9.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.7e-06	9.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.68e-06	9.02e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.68e-06	9.02e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.66e-06	9.01e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.64e-06	8.99e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.64e-06	8.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.64e-06	8.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.63e-06	8.97e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.62e-06	8.97e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.6e-06	8.95e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.53e-06	8.88e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.49e-06	8.84e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.48e-06	8.84e-05	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	9.42e-06	8.78e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.42e-06	8.78e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.41e-06	8.77e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.4e-06	8.76e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	9.3e-06	8.67e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.24e-06	8.61e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.21e-06	8.58e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.09e-06	8.47e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.07e-06	8.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	9.03e-06	8.42e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.97e-06	8.36e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.94e-06	8.33e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.9e-06	8.29e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.88e-06	8.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.81e-06	8.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.75e-06	8.16e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.75e-06	8.15e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.69e-06	8.1e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.68e-06	8.09e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	8.64e-06	8.05e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.61e-06	8.02e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.59e-06	8.01e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.57e-06	7.98e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.57e-06	7.98e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.55e-06	7.97e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.5e-06	7.92e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.49e-06	7.91e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.45e-06	7.87e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.44e-06	7.87e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.43e-06	7.86e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.42e-06	7.85e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.27e-06	7.7e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.19e-06	7.64e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.17e-06	7.61e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.15e-06	7.6e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.13e-06	7.58e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.1e-06	7.55e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.08e-06	7.53e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.07e-06	7.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.03e-06	7.48e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.96e-06	7.42e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.93e-06	7.39e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.87e-06	7.34e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.86e-06	7.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.83e-06	7.3e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.82e-06	7.29e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.8e-06	7.27e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.78e-06	7.25e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.76e-06	7.24e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.74e-06	7.21e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.73e-06	7.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.7e-06	7.18e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.61e-06	7.1e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.6e-06	7.08e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.57e-06	7.05e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.53e-06	7.01e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.47e-06	6.96e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.46e-06	6.95e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.45e-06	6.94e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.43e-06	6.92e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.42e-06	6.91e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.39e-06	6.88e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	7.34e-06	6.84e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.32e-06	6.82e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.26e-06	6.76e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.23e-06	6.73e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.22e-06	6.73e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.21e-06	6.72e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.19e-06	6.7e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.11e-06	6.63e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.08e-06	6.6e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.06e-06	6.58e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.06e-06	6.58e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.03e-06	6.55e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	7.02e-06	6.54e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.97e-06	6.49e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.95e-06	6.47e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.93e-06	6.46e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.87e-06	6.4e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.87e-06	6.4e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.87e-06	6.4e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.86e-06	6.39e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.76e-06	6.3e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.74e-06	6.28e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.72e-06	6.26e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.66e-06	6.21e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.63e-06	6.18e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.62e-06	6.17e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.62e-06	6.17e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.61e-06	6.16e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.59e-06	6.14e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.55e-06	6.11e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.53e-06	6.09e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.52e-06	6.08e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.49e-06	6.05e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.48e-06	6.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.45e-06	6.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.44e-06	6e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.44e-06	6e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.43e-06	5.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.41e-06	5.97e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.38e-06	5.94e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.35e-06	5.92e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.33e-06	5.9e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.31e-06	5.88e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.31e-06	5.88e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.3e-06	5.87e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.26e-06	5.84e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.25e-06	5.83e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.25e-06	5.83e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.2e-06	5.78e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.17e-06	5.75e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.15e-06	5.73e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.09e-06	5.68e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.09e-06	5.67e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6e-06	5.59e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.99e-06	5.58e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.97e-06	5.56e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.96e-06	5.55e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.87e-06	5.47e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.81e-06	5.42e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.8e-06	5.4e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.74e-06	5.35e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.72e-06	5.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.71e-06	5.32e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.7e-06	5.32e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.66e-06	5.28e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.63e-06	5.25e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.6e-06	5.22e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.57e-06	5.19e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.55e-06	5.18e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.53e-06	5.15e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.48e-06	5.11e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.45e-06	5.08e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.44e-06	5.07e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.43e-06	5.06e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.38e-06	5.01e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.35e-06	4.99e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.33e-06	4.97e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.33e-06	4.96e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.28e-06	4.92e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.26e-06	4.9e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.25e-06	4.89e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.2e-06	4.85e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.2e-06	4.85e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.2e-06	4.85e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.17e-06	4.82e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.16e-06	4.81e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.12e-06	4.77e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.11e-06	4.77e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.07e-06	4.73e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.07e-06	4.72e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.02e-06	4.68e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.01e-06	4.67e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.01e-06	4.67e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.99e-06	4.65e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.95e-06	4.61e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.94e-06	4.6e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.91e-06	4.58e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.88e-06	4.55e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.85e-06	4.52e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.85e-06	4.52e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.84e-06	4.51e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.82e-06	4.49e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.81e-06	4.48e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.78e-06	4.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.78e-06	4.45e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.73e-06	4.4e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.72e-06	4.4e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.71e-06	4.39e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.7e-06	4.38e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.68e-06	4.36e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.66e-06	4.35e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.65e-06	4.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.64e-06	4.32e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.61e-06	4.3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.6e-06	4.28e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.59e-06	4.27e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.57e-06	4.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.55e-06	4.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.33e-06	4.04e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.33e-06	4.03e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.27e-06	3.98e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.26e-06	3.97e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.26e-06	3.97e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.25e-06	3.96e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.23e-06	3.94e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.21e-06	3.92e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.18e-06	3.9e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.18e-06	3.89e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.17e-06	3.89e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.09e-06	3.82e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.06e-06	3.79e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.04e-06	3.77e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.93e-06	3.66e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.88e-06	3.62e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.87e-06	3.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.85e-06	3.59e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.8e-06	3.55e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.72e-06	3.47e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.7e-06	3.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.6e-06	3.35e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.57e-06	3.33e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.54e-06	3.3e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.51e-06	3.27e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.5e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.44e-06	3.2e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.27e-06	3.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.21e-06	2.99e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.21e-06	2.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.19e-06	2.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.15e-06	2.93e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.13e-06	2.91e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.99e-06	2.79e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.92e-06	2.72e-05	CbGpPWpGaD
